|
US4419340A
(en)
*
|
1969-03-24 |
1983-12-06 |
University Of Delaware |
Controlled release of anticancer agents from biodegradable polymers
|
|
GB1578323A
(en)
*
|
1976-02-26 |
1980-11-05 |
Rustenburg Platinum Mines Ltd |
Compositions containing platinum
|
|
GB1585103A
(en)
*
|
1976-04-06 |
1981-02-25 |
Rustenburg Platinum Mines Ltd |
Pharmaceutical compositions containing platinum compounds
|
|
US4255417A
(en)
*
|
1976-08-04 |
1981-03-10 |
Johnson Matthey, Inc. |
Platinum compounds for the irradication of skin blemishes
|
|
US4115418A
(en)
*
|
1976-09-02 |
1978-09-19 |
Government Of The United States Of America |
1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
|
|
JPS6041077B2
(ja)
*
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
|
|
US4151185A
(en)
*
|
1977-05-02 |
1979-04-24 |
Research Corporation |
Complex or salt of a platinum (II) compound and a nitrogen containing polymer
|
|
US4278660A
(en)
*
|
1977-05-02 |
1981-07-14 |
Research Corporation |
Complex or salt of a platinum (II) compound and a nitrogen containing polymer
|
|
US4137248A
(en)
*
|
1977-08-29 |
1979-01-30 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof
|
|
JPS5829957B2
(ja)
*
|
1977-09-12 |
1983-06-25 |
喜徳 喜谷 |
新規な白金錯体
|
|
SE447385B
(sv)
*
|
1977-10-19 |
1986-11-10 |
Johnson Matthey Co Ltd |
Cis-koordinationsforeningar av platina
|
|
US4225529A
(en)
*
|
1977-10-19 |
1980-09-30 |
Johnson, Matthey & Co., Limited |
Compositions containing platinum
|
|
DE2845371A1
(de)
*
|
1977-10-19 |
1979-04-26 |
Johnson Matthey Co Ltd |
Platinkomplexverbindung, pharmazeutische stoffzusammensetzung mit einer solchen verbindung und deren anwendung
|
|
NL7807334A
(nl)
*
|
1978-07-06 |
1980-01-08 |
Tno |
Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
|
|
US4405757A
(en)
*
|
1979-09-14 |
1983-09-20 |
Howell Bobby A |
Macromolecular complexes of amidocarbonylic water-soluble polymers and square planar platinous and equivalent organometallics
|
|
US4578491A
(en)
*
|
1982-06-28 |
1986-03-25 |
Engelhard Corporation |
Bis(thiocyanato)palladium(II) complexes
|
|
IT1153974B
(it)
*
|
1982-09-23 |
1987-01-21 |
Erba Farmitalia |
Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
|
|
US4560782A
(en)
*
|
1982-11-19 |
1985-12-24 |
Research Corporation |
Anti-tumor diplatinum coordination compounds
|
|
US4533502A
(en)
*
|
1983-02-22 |
1985-08-06 |
Rochon Fernande D |
Platinum (II) compounds and their preparation
|
|
IL71804A
(en)
*
|
1983-05-10 |
1989-06-30 |
Andrulis Res Corp |
Bis-(platinum diamine)complexes and antitumor pharmaceutical compositions containing the same
|
|
US4544759A
(en)
*
|
1983-07-29 |
1985-10-01 |
American Cyanamid Company |
Platinum complexes of antitumor agents
|
|
US4588831A
(en)
*
|
1984-11-09 |
1986-05-13 |
Natec |
Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
|
|
US5384127A
(en)
*
|
1985-10-18 |
1995-01-24 |
Board Of Regents, The University Of Texas System |
Stable liposomal formulations of lipophilic platinum compounds
|
|
US5041581A
(en)
*
|
1985-10-18 |
1991-08-20 |
The University Of Texas System Board Of Regents |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US5117022A
(en)
*
|
1985-10-18 |
1992-05-26 |
The Board Of Regents, The University Of Texas System |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US5393909A
(en)
*
|
1988-11-22 |
1995-02-28 |
Board Of Regents, The University Of Texas System |
Diamine platinum complexes as antitumor agents
|
|
US5434256A
(en)
*
|
1988-11-22 |
1995-07-18 |
Board Of Regents, The University Of Texas System |
Diamine platinum complexes as antitumor agents
|
|
US5041578A
(en)
*
|
1988-11-22 |
1991-08-20 |
Board Of Regents, The University Of Texas System |
Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
|
|
US5843475A
(en)
*
|
1996-12-06 |
1998-12-01 |
Board Of Regents, The University Of Texas System |
Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
|
|
CN1196630C
(zh)
*
|
1999-09-14 |
2005-04-13 |
史密丝克莱恩比彻姆公司 |
容器封闭系统
|
|
WO2001036431A1
(en)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
AU2004264421B2
(en)
|
2003-08-13 |
2011-02-24 |
University Of South Florida |
Platinum complexes for the treatment of tumors
|
|
US20050288365A1
(en)
*
|
2004-01-06 |
2005-12-29 |
Heidi Kay |
Platinum complexes and methods for inhibiting tumor cell proliferation
|
|
CA2587779A1
(en)
*
|
2004-11-10 |
2007-01-18 |
University Of South Florida |
Platinum complexes for targeted drug delivery
|
|
WO2007006019A1
(en)
*
|
2005-07-06 |
2007-01-11 |
University Of South Florida |
Materials and methods for screening, diagnosis and prognosis of conditions associated with stat protein expression
|
|
EP2036550A4
(en)
|
2006-06-28 |
2009-07-15 |
Ihi Corp |
MEDICAMENT, DRUG DELIVERY DEVICE, MAGNETIC DETECTOR, AND DRUG DESIGN METHOD
|
|
JP4774536B2
(ja)
*
|
2006-11-06 |
2011-09-14 |
株式会社Ｉｈｉ |
磁性材料、磁性材料の誘導装置及び磁性材料の設計方法
|
|
US20090169484A1
(en)
|
2007-12-28 |
2009-07-02 |
Ihi Corporation |
Iron-salen complex
|
|
JP5513405B2
(ja)
|
2008-11-20 |
2014-06-04 |
株式会社Ｉｈｉ |
自己磁性金属サレン錯体化合物
|
|
WO2011160063A2
(en)
|
2010-06-18 |
2011-12-22 |
Myriad Genetics, Inc. |
Methods and materials for assessing loss of heterozygosity
|
|
DK2609216T3
(en)
|
2010-08-24 |
2016-09-12 |
Dana Farber Cancer Inst Inc |
Methods to predict anti-cancer response
|
|
CA2839210A1
(en)
|
2011-06-17 |
2012-12-20 |
Myriad Genetics, Inc. |
Methods and materials for assessing allelic imbalance
|
|
EP2794907B2
(en)
|
2011-12-21 |
2022-11-23 |
Myriad Genetics, Inc. |
Methods and materials for assessing loss of heterozygosity
|
|
CA2864481C
(en)
|
2012-02-23 |
2020-07-14 |
The Children's Hospital Corporation |
Methods for predicting anti-cancer response
|
|
CA3126823C
(en)
|
2012-06-07 |
2023-04-04 |
Institut Curie |
Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
|
|
WO2014160080A1
(en)
|
2013-03-14 |
2014-10-02 |
Children's Medical Center Corporation |
Cancer diagnosis, treatment selection and treatment
|
|
PT2981624T
(pt)
|
2013-04-05 |
2020-03-23 |
Myriad Genetics Inc |
Métodos para avaliar deficiência na recombinação homóloga e prever resposta a tratamento para cancro
|
|
EP3080292B1
(en)
|
2013-12-09 |
2022-02-02 |
Institut Curie |
Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
|
|
WO2016025958A1
(en)
|
2014-08-15 |
2016-02-18 |
Myriad Genetics, Inc. |
Methods and materials for assessing homologous recombination deficiency
|
|
EP4141127A1
(en)
|
2021-08-30 |
2023-03-01 |
Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln |
Method for assessing homologous recombination deficiency in ovarian cancer cells
|